The relevance of TNFAIP3 in cutanous defense
The relevance of TNFAIP3 in cutanous defense
批准号:
280730632
负责人:
Dr. Maren Simanski
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antimicrobial peptides (AMP) are important effector molecules in epithelial defense. They are promptly induced by contact with microorganisms and antimicrobial effective in low concentrations. In our research on signal transduction of AMP we got hints that the human regulator protein TNFAIP3, which was originally found due to its protecting properties in TNF-alpha induced apoptosis, inhibits the bacteria-induced expression of AMP in keratinocytes. TNFAIP3 also seems to negatively regulate the bacterial induction of proinflammatory cytokines like IL-17C. Furthermore we have preliminary results that the expression of TNFAIP3 in keratinocytes is up regulated after infection with Staphylococcus aureus and Pseudomonas aeruginosa. Taken together these results lead to our hypothesis that bacteria are able to upregulate the human regulatory protein TNFAIP3, leading to decreased expression of defense molecules like AMP and cytokines, which implies advantages for the bacterias survival. In the requested project we want to prove this hypothesis. Antimicrobial peptides and cytokines are moreover strongly up regulated in the common inflammatory skin disease psoriasis. Furthermore psoriasis-associated TNFAIP3-gene polymorphisms exist. We want to investigate a potential relation between expression level of TNFAIP3 and concentrations of AMP and psoriasis-associated cytokines in the requested project. However in atopic dermatitis (AD) the expression of AMP is lower and AD-patients are - in contrast to psoriasis patients - prevalently affected with S. aureus infections. To date there are no studies about a correlation between TNFAIP3 and atopic dermatitis. Based on our preliminary results we hypothesize an increased TNFAIP3-expression in skin of atopic dermatitis patients, which would accompany with lower AMP-expression levels. We also want to investigate this point in the requested project to support new information for potential new therapeutic approaches.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Staphylococcus epidermidis-induced Interleukin-1 Beta and Human Beta-defensin-2 Expression in Human Keratinocytes is Regulated by the Host Molecule A20 (TNFAIP3).
表皮葡萄球菌诱导的人角质形成细胞中白细胞介素 1 Beta 和人 Beta 防御素 2 的表达受宿主分子 A20 (TNFAIP3) 的调节
DOI:
10.2340/00015555-3073
发表时间:
2019
期刊:
Acta dermato-venereologica
影响因子:
3.6
作者:
[Simanski M, Erkens A, Rademacher F, Harder J]
通讯作者:
Harder J
国内基金
海外基金
登录
查看更多内容
LncRNA GAS5竞争性结合外泌体miR-21-5p靶向TNFAIP3调控巨噬细胞极化促进肩袖腱骨界面修复作用的机制研究
-
批准号:2025JJ80589
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:毛晓东
-
依托单位:
REST靶向TRIM54/IRF1/TNFAIP3调控轴促进铁死亡抑制乳腺癌进展的作用机制研究
-
批准号:2025JJ50690
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘英
-
依托单位:
TNFAIP3 通过去泛素化调控 BST2 蛋白稳定性
促进子宫内膜异位症发生发展的机制研究
-
批准号:Q24H040012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨心运
-
依托单位:
核激活miR-424调控TNFAIP3介导Parthanatos在亨廷顿病中的发病机制研究
-
批准号:82301613
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:程扬帆
-
依托单位:
骨骼干细胞通过释放免疫因子TNFAIP3调节巨噬细胞坏死性凋亡减轻骨关节炎骨软骨损伤及相关机制研究
-
批准号:82372373
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:朱恒
-
依托单位:
METTL14调控TNFAIP3 m6A甲基化促进类风湿关节炎炎症反应的机制及诊断价值研究
-
批准号:82302019
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:汤纪丰
-
依托单位:
CTCF靶向激活TNFAIP3在NZnOC调控山羊肠道菌群时空动态定植-BA代谢-肠黏膜免疫中的作用机制
-
批准号:32360855
-
项目类别:地区科学基金项目
-
资助金额:31万元
-
批准年份:2023
-
负责人:张海波
-
依托单位:
TRIM2介导内皮细胞TNFAIP3泛素化修饰在急性肺损伤中的作用及机制研究
-
批准号:82360385
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:陈世彪
-
依托单位:
lnc-KIAA1244-2作为miR-4291的ceRNA调控TNFAIP3表达在降低食管鳞癌对PD-1抑制剂敏感性的机制研究
-
批准号:82260550
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:马军亮
-
依托单位:
METH所致中枢神经系统炎症损伤中TNFAIP3对星形胶质细胞异质性作用机制的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:乔东访
-
依托单位: